Skip to content
Screener

Eton Pharmaceuticals, Inc. ETON Deferred Revenue

Deferred Revenue at other companies

HRO
HarrowHROW
$106K+16.5%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$5.55M-62.2%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$498K-96.1%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$12.32M—
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$684.8M+42.1%

Segments

By product

See full
Increlex$457K-82.0%

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K—
Free cash flow$7.3M+251%

Valuation

See full
Market cap$1.22B+162%
Enterprise value$1.23B+161%
P/S14.1×+6.0×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%—
Net margin-9.5%-2.7pp
FCF margin17.1%—

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity1×-0.2×
Current ratio1.2×-0.8×

FAQ

What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.